
Dose-Response Association of CD8 + Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
2017; American Medical Association; Volume: 3; Issue: 12 Linguagem: Inglês
10.1001/jamaoncol.2017.3290
ISSN2374-2445
AutoresEllen L. Goode, Matthew S. Block, Kimberly R. Kalli, Robert A. Vierkant, Wenqian Chen, Zachary C. Fogarty, Aleksandra Gentry‐Maharaj, Aleksandra Tołoczko, Alexander Hein, Aliecia L. Bouligny, Allan Jensen, Ana Osório, Andreas D. Hartkopf, Andy Ryan, Anita Chudecka-Głaz, Anthony M. Magliocco, Arndt Hartmann, Audrey Jung, Bo Gao, Brenda Y. Hernandez, Brooke L. Fridley, Bryan M. McCauley, Catherine J. Kennedy, Chen Wang, Chloe Karpinskyj, Christiani Bisinoto de Sousa, Daniel Guimarães Tiezzi, David L. Wachter, Esther Herpel, Florin‐Andrei Taran, Francesmary Modugno, Gregg Nelson, Jan Lubiński, Janusz Menkiszak, Jennifer Alsop, Jenny Lester, Jesús García-Donás, Jill Nation, Jillian A. Hung, José Palacios, Joseph H. Rothstein, Joseph L. Kelley, Jurandyr Moreira de Andrade, Luis A. Díaz‐Robles, Maria P. Intermaggio, Martin Widschwendter, Matthias W. Beckmann, Matthias Ruebner, Mercedes Jimenez‐Liñan, Naveena Singh, Oleg Oszurek, Paul R. Harnett, Peter Rambau, Hans‐Peter Sinn, Philipp Wagner, Prafull Ghatage, Raghwa Sharma, Robert P. Edwards, Roberta B. Ness, Sandra Oršulić, Sara Y. Brucker, Sharon E. Johnatty, Teri A. Longacre, Ursula Eilber, Valerie McGuire, Weiva Sieh, Yanina Natanzon, Zheng Li, Alice S. Whittemore, Anna deFazio, Annette Staebler, Beth Y. Karlan, C. Blake Gilks, David D.L. Bowtell, Estrid Høgdall, Francisco José Cândido dos Reis, Helen Steed, Ian Campbell, Jacek Gronwald, Javier Benı́tez, Jennifer M. Koziak, Jenny Chang‐Claude, Kirsten B. Moysich, Linda E. Kelemen, Linda S. Cook, Marc T. Goodman, María J. García, Peter A. Fasching, Stefan Kommoss, Suha Deen, Susanne K. Kjær, Usha Menon, James D. Brenton, Paul D.P. Pharoah, Georgia Chenevix‐Trench, David G. Huntsman, Stacey J. Winham, Martin Köbel, Susan J. Ramus,
Tópico(s)Ovarian cancer diagnosis and treatment
ResumoCytotoxic CD8+ tumor-infiltrating lymphocytes (TILs) participate in immune control of epithelial ovarian cancer; however, little is known about prognostic patterns of CD8+ TILs by histotype and in relation to other clinical factors.
Referência(s)